- Memorandum of Understanding Signed with Edogawa Hospital -

B dot Medical Inc. has signed a memorandum of understanding with Edogawa 
Hospital in Japan for the installation of the company's first practical 
ultra-compact proton therapy system, which means the first proton therapy 
facility to be established in Tokyo.

Logo: https://kyodonewsprwire.jp/img/202212211482-O2-n1O2n8B4

Image1: Edogawa Hospital in Tokyo, Japan
https://kyodonewsprwire.jp/prwfile/release/M105528/202212211482/_prw_PI3fl_q4R7xNxK.jpeg


Conventional proton therapy systems are very large and require a large space 
for installation. As a result, the installation of proton therapy in urban 
areas where land is scarce has been slow, and proton therapy has reached only a 
small percentage of patients. To overcome this situation, B dot Medical is 
working to commercialize an ultra-compact proton therapy system. This system is 
overwhelmingly more compact than conventional ones and can be installed in 
hospitals where it has been difficult to do it due to the size and cost of the 
system in the past.

Dr. Shojiro Kato, Director of Edogawa Hospital, commented: "We are very pleased 
that once our hospital is able to offer proton therapy, we will be able to 
treat patients who have not previously been able to receive proton therapy in 
Tokyo. We will continue to provide medical care in pursuit of the best possible 
outcome for all patients."

Takuji Furukawa, Chief Executive Officer of B dot Medical, added: "Three and a 
half years have passed since we started developing an ultra-compact proton 
therapy system to bring more advanced cancer treatment to as many patients as 
possible, and we are finally one step closer to realizing our dream. We hope 
that the installation of this system will expand the treatment options for many 
cancer patients. We will do our utmost to obtain approval for the system, 
install it, start treatment, and provide support afterward."

B dot Medical will continue its efforts to obtain PMDA (Pharmaceuticals and 
Medical Devices Agency) approval in Japan, aiming for a society in which cancer 
patients around the world can choose proton therapy.

About B dot Medical Inc.
B dot Medical Inc. is a start-up that originated at the National Institute of 
Radiological Sciences (NIRS) and is developing an ultra-compact proton therapy 
system by utilizing the advanced technology and experience cultivated at NIRS. 
The company is challenging the world with Japanese technological innovation 
power.

Image2: Ultra-compact proton therapy system under development
https://kyodonewsprwire.jp/prwfile/release/M105528/202212211482/_prw_PI4lg_1i4xoCzD.jpg


Company Information
Name: B dot Medical Inc.
Address: 5-10-10 Harue-cho, Edogawa-ku, Tokyo 134-0003 JAPAN
Representative: Takuji Furukawa, President and CEO
Foundation: March 1, 2017
Business activity: 
1) Consulting support for particle therapy
2) Developing proton therapy systems

Website: https://bdotmed.co.jp/en/


Source: B dot Medical Inc.